RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Recent epidemiological studies have revealed that osteoporosis is closely associated with common chronic diseases including diabetes, hypertension, chronic kidney disorders, and chronic obstructive pulmonary disease (COPD). COPD is a chronic inflammatory airway disease but now well known to be associated with various systemic comorbidities including osteoporosis. Osteoporosis and osteoporotic fractures are extremely common in COPD patients, which have significant impacts on their quality of life (QOL), activities of daily life (ADL), respiratory function, and possibly their prognosis. COPD-associated osteoporosis is however extremely under-recognized, hence undertreated. Recent studies have suggested that both decreased bone mineral density (BMD) and impaired bone quality compromise bone strength causing fractures in COPD. In COPD patients, various general clinical risk factors for osteoporosis are present including smoking, older age, low body weight, and physical inactivity. In addition, disease-related risk factors such as decreased pulmonary function, inflammation, glucocorticoid use and vitamin D deficiency/insufficiency have been linked to the development of osteoporosis in COPD. Increased awareness of osteoporosis in COPD, especially that of high prevalence of vertebral fractures is called upon among general physicians as well as pulmonologists. Routine screening for osteoporosis and risk assessment of fractures will enable physicians to diagnose COPD patients with comorbid osteoporosis at an early stage.
Timely prevention of developing osteoporosis together with appropriate treatment of established osteoporosis may improve QOL and ADL of the COPD patients, preserve their lung function and eventually result in better prognosis in these patients.

번역하기

참고문헌 (Reference)

1 Martineau AR, "Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial" 3 : 120-130, 2015

2 Romme EA, "Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease" 45 : 91-96, 2013

3 Førli L, "Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease" 256 : 56-62, 2004

4 Janssens W, "Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene" 65 : 215-220, 2010

5 Zhu B, "Vitamin D deficiency is associated with the severity of COPD : a systematic review and meta-analysis" 10 : 1907-1916, 2015

6 Janssens W, "Vitamin D and chronic obstructive pulmonary disease: hype or reality?" 1 : 804-812, 2013

7 Ebeling PR, "Vitamin D and bone health : Epidemiologic studies" 3 : 511-, 2014

8 Nuti R, "Vertebral fractures in patients with chronic obstructive pulmonary disease : the EOLO Study" 20 : 989-998, 2009

9 Silva BC, "Trabecular bone score : a noninvasive analytical method based upon the DXA image" 29 : 518-530, 2014

10 Jeon YK, "The relationship between pulmonary function and bone mineral density in healthy nonsmoking women : the Korean National Health and Nutrition Examination Survey(KNHANES)2010" 25 : 1571-1576, 2014